The Manufacturers Life Insurance Company Decreases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

The Manufacturers Life Insurance Company lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 82.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 97,161 shares of the company’s stock after selling 442,928 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.08% of Henry Schein worth $6,724,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Lyrical Asset Management LP bought a new stake in shares of Henry Schein during the 4th quarter valued at $126,655,000. Norges Bank purchased a new stake in Henry Schein in the fourth quarter valued at approximately $103,301,000. National Bank of Canada FI lifted its holdings in shares of Henry Schein by 102.4% during the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company’s stock worth $75,048,000 after acquiring an additional 548,561 shares during the last quarter. Raymond James Financial Inc. bought a new position in Henry Schein in the fourth quarter valued at $34,720,000. Finally, Clarkston Capital Partners LLC raised its position in Henry Schein by 24.8% during the fourth quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company’s stock valued at $120,700,000 after purchasing an additional 346,420 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of research reports. UBS Group cut their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. Barrington Research lowered their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday. StockNews.com downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Finally, Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $79.30.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC opened at $66.24 on Wednesday. The business’s 50 day moving average price is $67.78 and its 200-day moving average price is $71.51. The stock has a market cap of $8.12 billion, a P/E ratio of 27.26, a P/E/G ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the firm posted $1.10 EPS. Henry Schein’s revenue for the quarter was down .1% on a year-over-year basis. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.